Pain killer Aspirin reduces the breast cancer risk by about 20%, according to a latest research study by British doctors. Scientists conducted 21 analytical studies on 37,000 women to find the beneficial effects of Aspirin on Breast cancer treatment. But researchers advised caution and requirement for more research before coming to conclusion on recommending to Aspirin to breast cancer patients. Aspirin is already using by many women as a preventive drug for heart attacks and strokes. But Aspirin use along with Breast cancer drugs and their interactions still needs extensive research. Long term use of Aspirin is associated with side effects like stomach ulcers, kidney problems and bleeding.
This research study was published in the “International Journal of Clinical Practice (IJCP)”.
